Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;187(4):464-471.
doi: 10.1111/bjd.21698. Epub 2022 Jul 12.

Chronic prurigo

Affiliations
Review

Chronic prurigo

Laurent Misery. Br J Dermatol. 2022 Oct.

Abstract

Chronic prurigo is a distinct disease defined by the presence of chronic pruritus for at least 6 weeks, a history and/or signs of repeated scratching, and multiple localized or generalized pruritic skin lesions (whitish or pinkish papules, nodules and/or plaques). Although chronic prurigo is frequently named prurigo nodularis, the nodular type of chronic prurigo is only the main clinical aspect of chronic prurigo. Chronic prurigo occurs due to neural sensitization to pruritus and the development of a vicious pruritus-scratching cycle. Chronic prurigo can be of allergological, dermatological, systemic, neurological, psychiatric/psychosomatic, mixed or undetermined origin. The prevalence is still debated. The burden is high. Current treatments often remained disappointing. Fortunately, recent research results on the pathophysiology of pruritus evidenced neuroimmune interactions and allow new therapeutic perspectives. Among them, antagonists of T-helper 2 cytokines, κ-opioids and Janus kinase inhibitors may be promising. What is already known about this topic? Chronic prurigo or prurigo nodularis is poorly known by dermatologists and the definition was rather vague until recently. What does this study add? This review provides a summary of the recent developments of nosology and research (from basic research to epidemiology and clinical research), and current and near-future management are then discussed.

PubMed Disclaimer

References

    1. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361:690-4.
    1. Misery L, Ständer S. Pruritus. London: Springer, 2017.
    1. Misery L, Brenaut E, Le Garrec R et al. Neuropathic pruritus. Nat Rev Neurol 2014; 10:408-16.
    1. Weisshaar E, Szepietowski JC, Dalgard FJ et al. European S2k Guideline on Chronic Pruritus. Acta Derm Venereol 2019; 99:469-506.
    1. Ständer S, Weisshaar E, Mettang T et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007; 87:291-4. https://doi.org/10.2340/00015555-0305.